Wall Street Beat
NuVasive reiterates 2013 sales guidance
Merck backs Medivo in $15M in Series B round
Medtronic ticks up on share buyback, dividend
Wright Medical gets out of the hip and knee biz for $290M
Wright Medical (NSDQ:WMGI) said it agreed to sell its OrthoRecon hip and knee business to Hong Kong-based MicroPort Scientific (HK:0853) for $290 million in cash.
Covidien’s Mallinckrodt pharma spinout slated to close this month | Wall Street Beat
Covidien (NYSE:COV) said it expects to close its spinout of the Mallinckrodt pharmaceuticals business by the end of this month, with a distribution of shares in the new company.
Mansfield, Mass.-based Covidien said it will issue 1 single share of Mallinckrodt stock for 8 shares of COV stock to interested investors, will all distributions scheduled for completion by June 28.
CareFusion may be weighing 2 very different deals
Smarter strategic moves bode well for Wright Medical
There’s a saying in the markets that there’s always a bull market somewhere. Along similar lines, it’s almost always possible to find areas of growth in otherwise stagnant med-tech markets. While the overall performance of the orthopedic market has been pretty uninspiring of late, the extremities sub-sectors (upper and lower extremities) have been notable exceptions.
Mindray Medical to drop $105M on Zonare
Abbott OKs $3B share buyback, dividend
Covidien CEO Almeida wants more from emerging markets | Wall Street Beat
Medical device giant Covidien is doubling down on emerging markets, expanding an investment program that the company had, at one point, thought would be over by the end of 2013.